Women's Healthcare Forum

Jointly Sponsored
by

and

WHF

Anaheim Learning Objectives

Abnormal Uterine Bleeding (AUB), Myomas, and Polyps

Faculty Paul F. Brenner, MD Professor, Vice Chairman Department of Obstetrics and Gynecology Keck School of Medicine University of Southern California Los Angeles, CA Learning Objectives Outline the differential diagnosis for women who present with abnormal uterine bleeding (AUB) in order to determine the specific cause of bleeding Review the diagnostic advances in early detection of ectopic pregnancy and evaluate less invasive nonsurgical medical procedures to reduce complications in patients not in danger of tubal rupture and hemorrhage Distinguish uterine tumors from ovarian or other tumors in the diagnosis of leiomyoma of the uterus to improve health outcomes Cite factors pertaining to the management of women with leiomyoma of the uterus to individualize patient care Explain the risks and benefits of available medical and surgical treatments for dysfunctional uterine bleeding and uterine leiomyomas in order to involve patients in the decision-making process

ALZHEIMER'S DISEASE IN WOMEN
Faculty Jack D. Schim, MD The Neurology Center Encinitas, CA Codirector, The Headache Center of Southern California Assistant Clinical Professor of Neurology University of California, San Diego San Diego, CA Learning Objectives Identify the demographics and prevalence of Alzheimer's disease in order to screen appropriately and increase potential for early detection Review risk factors for Alzheimer's disease in order to recommend to patients preventive strategies that may mitigate the onset and advance of dementia or cognitive decline Assess current evidence-based nonpharmacological and pharmacological treatment options for Alzheimer's disease and dementia in order to implement appropriate management strategies and improve patient quality of life

AN UPDATE ON OSTEOPOROSIS Supported by an educational grant to the FBHC from Merck & Co., Inc
Faculty Lila E. Nachtigall, MD Professor of Obstetrics and Gynecology Director, Women's Wellness Co-Director, Bone Density Unit New York University School of Medicine New York, NY Learning Objectives Review the physical and psychological consequences of osteoporosis and utilize this information to tailor treatment options for decreased patient morbidity and improved quality of life Discuss current osteoporosis guidelines in order to recognize those at high risk and incorporate earlier and more aggressive treatment interventions for improved physical and emotional outcomes Interpret bone mineral density measurement reports and T-score assessments in the diagnosis of osteoporosis and utilize this information to make more consistent and efficient diagnoses for improved patient treatment " Differentiate between various antiresorptive and anabolic agents for treating and preventing osteoporosis and integrate new therapies for improved bone mineral density levels " Cite other nonpharmacologic and pharmacologic treatment options and incorporate therapies into current patient regimen to improve quality of life and prevent future deterioration and events

ANXIETY AND DEPRESSION IN WOMEN: MIDLIFE AND BEYOND Supported by an Educational grant to the FBHC from Wyeth Pharmaceuticals
Faculty Vivien K. Burt, MD, PhD Professor of Psychiatry David Geffen School of Medicine Women's Life Center of the Resnick Neuropsychiatric Hospital University of California, Los Angeles Los Angeles, CA Learning Objectives Review current clinical guidelines for the diagnosis and treatment of depression in women in order to make earlier and more accurate diagnoses for improved patient care List current guideline-based recommendations for the treatment of depression in women to optimize outcomes for patients Discuss menopausal, as well as peri- and postmenopausal, risk factors for depression and cite the pharmacotherapy and psychotherapy that can be implemented to treat patients' symptoms at midlife and beyond Analyze the risks to patients of inadequately treating depression and discuss the safety of available medications, especially SSRIs, to determine an appropriate risk-benefit approach to treatment

BREAST CANCER: A PRIMARY CARE CONCERN
Faculty Lila E. Nachtigall, MD Professor of Obstetrics and Gynecology Director, Women's Wellness Co-Director, Bone Density Unit New York University School of Medicine New York, NY Learning Objectives Review updated guidelines for breast cancer screening and employ recommended screening techniques in average- and high-risk patients to make earlier referrals to specialists and provide accurate diagnoses for improved patient survival Describe the role of adjuvant aromatase inhibitors and other newer agents as effective alternative or supplemental therapy to tamoxifen to improve patient outcomes Examine current recommendations for follow-up of asymptomatic breast cancer survivors, and instruct patients about the importance of diet and lifestyle behavior modifications to help them remain cancer-free Define supportive care strategies for psychosocial issues, chemotherapy side effects, adverse effects of treatment, and rehabilitation in order to improve patients' quality of life and sense of well-being during and after cancer recovery

CATCH THE NEW SEXUALLY TRANSMITTED DISEASE UPDATE
Faculty JoAnn Woodward, RNC, BSN, NP Maricopa Obstetrics and Gynecology Associates Phoenix, AZ Learning Objectives Identify the most recent standards for the diagnosis and treatment of sexually transmitted infections (STIs) to ensure the best care at the earliest stage of infection Demonstrate the role of primary care physicians and gynecologists in the containment of STIs to reduce their incidence and ramifications for patients Examine the threat of drug-resistant strains of N gonorrhoeae in order to provide patients with treatment that will eradicate the infection and reduce the likelihood of future resistance to treatment Define the at-risk population for syphilis and describe the latest methodologies for screening and treatment in order to protect high-risk patients from infection and provide early treatment for infected patients Describe the most recent advances in the diagnosis and treatment of herpes simplex virus (HSV) to reduce incidence and promote early and effective treatment

CHRONIC PELVIC PAIN SYNDROME: CLINICAL CHARACTERISTICS AND MANAGEMENT
Faculty Ursula Wesselmann, MD, PhD Associate Professor Department of Neurology Johns Hopkins University School of Medicine Baltimore, MD Learning Objectives Review the latest updates on the diagnosis and management of CPP to make earlier diagnoses and referrals for improved patient outcomes Recognize the various gynecologic and nongynecologic causes of CPP in order to develop the best available treatment options to reduce pain and improve patient comfort Cite recent advances in the treatment of CPP and compare the efficacy and safety of available interventions to improve patient outcomes Discuss multidisciplinary pain management treatment in order to differentiate appropriate psychological, medical, and/or surgical approaches that will decrease patient morbidity and minimize symptoms

COLORECTAL CANCER 2007: PUBLIC HEALTH FAILURES AND TARGETED THERAPY SUCCESSES
Faculty J. Randolph Hecht, MD Clinical Professor of Medicine Director, Gastrointestinal Oncology Program David Geffen School of Medicine University of California, Los Angeles Los Angeles, CA Learning Objectives Define the key risk factors for colon cancer and identify at-risk patients for early screening and improved prevention Review current guidelines for screening techniques, including frequency, for colorectal cancer and utilize these recommendations for average-, increased-, and high-risk patients to make early diagnoses and improve patient survival Evaluate approved treatment options including new chemotherapy and targeted agents for colorectal cancers and implement recommended treatment techniques to improve clinical outcomes and reduce morbidity

COMPLEMENTARY AND ALTERNATIVE MEDICINE: AN UPDATE Supported by an educational grant to the FBHC from Boehringer Ingelheim Pharmaceuticals and Pfizer, Inc
Faculty Tieraona Low Dog, MD Director of Education Program in Integrative Medicine Clinical Assistant Professor Department of Medicine University of Arizona School of Medicine Tucson, AZ Learning Objectives Recognize the widespread use of complementary and alternative medicine (CAM) by women residing in the US and incorporate respectful dialogues about CAM treatments into patient consultations in order to maintain open communication Review the data on CAM for treatment of menopausal symptoms and discuss the efficacy of popular therapies with menopausal patients to optimize symptom management Assess the evidence for alternative therapeutic options for depression and identify patients in your practice who could potentially benefit from such therapies Cite the use of CAM modalities for the treatment of premenstrual syndrome (PMS) and educate patients on the potential use and misuse of various CAM interventions for this disorder

COMPLEMENTARY AND ALTERNATIVE MEDICINE FOR PAIN IN WOMEN: THE EVIDENCE AND PRACTICAL APPROACHES
Faculty James N. Dillard, MD Medical Director Rosenthal Center Columbia University Medical Center The New York Presbyterian Hospitals New York, NY Learning Objectives Cite complementary and alternative medicine (CAM) therapies showing the best evidence for the treatment of pain and review their efficacy in the management of painful conditions in your female patients Describe the most effective conventional medicine therapeutic approaches for treatment of the common painful conditions in women Discuss how integrative medicine approaches to painful conditions in women might be practically executed in the out-patient and in-patient settings

CONTRACEPTION: OPTIMIZING PATIENT CHOICES
Faculty Lee P. Shulman, MD Professor and Chief Division of Reproductive Genetics Department of Obstetrics and Gynecology Feinberg School of Medicine Northwestern University Chicago, IL Learning Objectives Describe the types of oral contraceptive pills (OCPs) and review their efficacy in order to increase patient satisfaction, promote improved compliance, and prevent unintended pregnancy Discuss new methods of contraception and identify patients' best options in order to improve compliance and increase contraceptive success Review risks and complications associated with various OCPs pills to facilitate better patient choices improve safety, and reduce side effects Evaluate and implement contraceptive counseling to create regimens that are individualized to patient lifestyles and preferences

DIFFERENT STROKES FOR DIFFERENT FOLKS: PREVENTION ISSUES IN WOMEN
Faculty Jack D. Schim, MD The Neurology Center Encinitas, CA Codirector, The Headache Center of Southern California Assistant Clinical Professor of Neurology University of California, San Diego San Diego, CA Learning Objectives Cite the known modifiable and nonmodifiable risk factors for stroke in women to accurately assess overall risk and individualize treatment Discuss the value of antithrombotic treatments and their potential to reduce stroke risk in patients with atrial fibrillation Analyze female patients' cardiovascular (CV) risk factors in order to reduce CV risks when making oral hormone therapy and oral contraceptive prescribing decisions Assess patients' lipid profiles to determine stroke risk and utilize statin therapy when appropriate to reduce risks and prevent mortality

EARLY DIAGNOSIS, MANAGEMENT AND TREATMENT OF RHEUMATOID ARTHRITIS AND ANKYLOSING SPONGYLITIS Supported by an educational grant to the FBHC from Abbott Immunology
Faculty Arthur Kavanaugh, MD Professor of Medicine Division of Rheumatology, Allergy, and Immunology University of California, San Diego La Jolla, CA Learning Objectives Discuss the current guidelines and recommendations for treatment of rheumatoid arthritis (RA) and ankylosing spondylitis (AS) to optimize patient outcomes Recognize the importance of diagnosing RA and AS at onset in order to ensure that the patient receives treatment before permanent joint damage has occurred Integrate recent management strategies in your practice so that new therapeutic options can be appropriately used to improve patient outcomes

ENDOMETRIOSIS AND CHRONIC PELVIC PAIN Supported by an educational grant to the FBHC from TAP Pharmaceuticals, Inc.
Faculty Lee P. Shulman, MD Professor and Chief Division of Reproductive Genetics Department of Obstetrics and Gynecology Feinberg School of Medicine Northwestern University Chicago, IL Learning Objectives Review the symptoms associated with chronic pelvic pain (CPP) and endometriosis, as well as the diagnostic tools for recognizing these conditions, in order to better facilitate disease management in patients Delineate clinical methods for management of CPP and endometriosis so that the optimal therapeutic approach can be implemented for individual patients Compare the available surgical and drug therapy options for treating women who suffer from endometriosis Identify ways to handle endometriosis-associated pain and/or subfertility to improve patients' comfort and/or achieve pregnancy

HEADACHE IN WOMEN: A PRIMER ON THE DIAGNOSIS AND MANAGEMENT OF HEADACHE
Faculty Andrew M. Blumenfeld, MD Director, The Headache Center of Southern California Scripps Memorial Hospital-Encinitas Encinitas, CA Learning Objectives Cite the benefits of early migraine treatment to reduce the pain and discomfort resulting from delayed treatment Recognize the prevalence of and disabilities associated with migraine medication overuse and employ treatment strategies to promote long-term patient benefits and safety Assess the evidence for alternative therapies to oral headache medications and identify patients in your practice who could potentially benefit from such therapies


HIV/AIDS IN WOMEN Supported by an educational grant to the FBHC from Gilead Sciences, Inc.
Faculty Monica Gandhi MD, MPH Assistant Professor Division of Infectious Diseases Department of Medicine University of California, San Francisco San Francisco, CA Learning Objectives Cite the current treatment guidelines and management strategies to ensure that female patients receive optimal treatment Identify high-risk groups, distinguish warning signal symptoms of HIV infection, and recommend HIV testing with counseling to women so that early diagnosis will allow full access to antiretroviral therapies (ARTs) and preventive therapies for opportunistic infections Describe gender-specific differences in response to therapy and incidence of adverse events related to the use of highly active ART to treat HIV/AIDS in order to improve overall outcomes for female patients Discuss data on the impact of contraception use and pregnancy on antiretroviral pharmacokinetics and choice of ART to prevent transmission of HIV from infected mothers to newborns and ensure optimum patient outcome and child safety

INTEGRATIVE APPROACHES TO CARDIOVASCULAR DISEASE
Faculty Tieraona Low Dog, MD Director of Education Program in Integrative Medicine Clinical Assistant Professor Department of Medicine University of Arizona School of Medicine Tucson, AZ Learning Objectives Describe the prevalence and impact of cardiovascular disease (CVD) and identify key risk factors in women Discuss prevention strategies including lifestyle modifications and dietary interventions that can reduce the risk of heart disease Review the potential benefits and risks of alternative therapy in the prevention and/or treatment of heart disease to help patients make better healthcare choices and improve outcomes Evaluate the efficacy and safety evidence for complementary and alternative medicine commonly used for prevention and/or treatment of CVD

MANAGEMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN WOMEN
Faculty Gerard M. Turino, MD John H. Keating Sr. Professor of Medicine College of Physicians and Surgeons (Emeritus) Columbia University Director, James P. Mara Center for Lung Disease St. Luke's-Roosevelt Hospital Center New York, NY Learning Objectives Review the process of pulmonary obstruction in COPD in order to better improve the overall management of COPD Evaluate management issues in patients with COPD, to best determine which patients will respond to which therapy Compare and contrast the process of airway narrowing in COPD with asthma in order to improve the health outcomes of those patients with asthma, COPD, or both diseases Describe effective treatment plans for acute exacerbations and long-term management of COPD to maximize patient outcomes

MANAGEMENT STRATEGIES FOR WOMEN WITH TYPE 2 DIABETES Supported by an educational grant to the FBHC from Takeda Pharmaceuticals North America, Inc.
Faculty George Dailey, MD Senior Consultant Division of Diabetes and Endocrinology Head, Diabetes Research Scripps Clinic Clinical Professor of Medicine University of California, San Diego La Jolla, CA Learning Objectives Describe current clinical guidelines for diabetes management and examine evidence for achieving tight targets for glycemic control in order to limit complications and improve outcomes in patients Discuss established and new approaches to managing patients with type 2 diabetes mellitus (T2DM) to institute early and aggressive treatment Review the data on the approved thiazolidinediones (TZDs) and describe how this therapy may be used most effectively in patients to improve their short- and long-term outcomes in the continuum of care

MANAGING INSOMNIA AND SLEEP DISORDERS IN WOMEN Supported by an educational grant to the FBHC from Takeda Pharmaceuticals North America, Inc.
Faculty Alon Avidan, MD, MPH Associate Professor Director, UCLA Neurology Clinic Associate Director, UCLA Sleep Disorders Center Department of Neurology University of California, Los Angeles Los Angeles, CA Learning Objectives Summarize current clinical guidelines for insomnia management and examine evidence for improving assessment and early diagnosis in female patients Cite health risks and lifestyle factors related to female-specific insomnia in order to identify high risk female patients and make early diagnoses Describe the pathophysiology of insomnia, specifically chronic insomnia, and compare the efficacy and safety of available pharmacologic and nonpharmacologic therapies in order to manage insomnia more effectively and improve treatment expectations in women Recognize the prevalence of insomnia in female patients and its negative impact on patients' quality of life in order to implement effective interventions and improve outcomes

MANAGING WOMEN WITH CHRONIC CONSTIPATION AND IRRITABLE BOWEL SYNDROME Supported by an educational grant to the FBHC from Sucampo Pharmaceuticals, Inc., and Takeda Pharmaceuticals North America, Inc.
Faculty Lin Chang, MD Professor of Medicine Center for Neurosvisceral Sciences and Women's Health Division of Digestive Diseases David Geffen School of Medicine University of California, Los Angeles VA Greater Healthcare System of Los Angeles Los Angeles, CA Learning Objectives Review symptom differences in the presentation of chronic constipation (CC) and irritable bowel syndrome (IBS) in women for improved diagnosis and treatment of female patients who suffer from these conditions Examine the symptoms and psychosocial features of CC/IBS and utilize current treatment options to diminish quality of life burdens Evaluate patient response to CC management strategies and integrate gender-specific treatment approaches to attain optimal control of symptoms Assess evidence-based data on the safety and efficacy of therapeutic options for CC and implement appropriate management strategies for individuals with CC to resolve gastrointestinal symptoms

MENOPAUSE, HORMONES, AND THE FUTURE: WHERE DO WE GO IN 2007 AND BEYOND?
Faculty Lila E. Nachtigall, MD Professor of Obstetrics and Gynecology Director, Women's Wellness Co-Director, Bone Density Unit New York University School of Medicine New York, NY Learning Objectives Examine the newest clinical data to recognize the impact of vasomotor symptoms on the quality of life in perimenopausal women and apply this knowledge in clinical practice to improve patient outcomes Assess the results of the WHI study and integrate them into your clinical decisions to optimize individual patient outcomes Review HT risks and benefits to better educate and counsel patients to make informed treatment decisions that result in safe and effective symptom relief Utilize the full range of therapeutic options to manage vasomotor symptoms in order to improve quality of life in perimenopausal women

METABOLIC SYNDROME AND DYSLIPIDEMIA IN WOMEN
Faculty Sandra J. Lewis, MD, FACC Clinical Associate Professor of Medicine Oregon Health and Science University Director of Cardiac Rehabilitation Legacy Good Samaritan Hospital Portland, OR Learning Objectives Define the metabolic syndrome and become familiar with its diagnostic criteria to better identify and manage patients presenting with the syndrome or aspects of it Identify the epidemiologic and clinical data supporting the benefits of weight loss, lipid control, hypertension management, and high glucose reduction to better understand how prevention and aggressive treatment can reduce cardiovascular and other health risks in the metabolic syndrome Review updated clinical guidelines for the management of lipids as established by the Adult Treatment Panel III guidelines and implement recommended treatment techniques to improve lipoprotein goals for patients Discuss current evidence-based guidelines for pharmacologic and nonpharmacologic treatments to achieve lipid goals and reduce morbidity and mortality of patients

OBESITY MANAGEMENT: A CHALLENGING ISSUE IN PRIMARY CARE
Faculty Susan Bowerman, MS, RD Assistant Director Center for Human Nutrition University of California, Los Angeles Los Angeles, CA Learning Objectives Discuss which behavior modifications for overweight and obese patients are effective in preventing disease and implement educational strategies that motivate these patients to achieve long-term positive changes Cite some of the obesity-related health risks that are specific to women to better educate and motivate obese patients to improve their health and well-being Review the importance of addressing obesity, providing routine screening to at-risk patients, and counseling on diet and physical activity in your clinical practice Discuss the benefits of dietary protein and improved success in the use of meal replacements for weight loss and maintenance efforts

PRACTICAL APPROACHES TO FIBROMYALGIA SYNDROME
Faculty Bill McCarberg, MD Founder Chronic Pain Management Program Kaiser Permanente, San Diego Assistant Clinical Professor (Voluntary) University of California, San Diego San Diego, CA Learning Objectives Summarize diagnostic criteria for fibromyalgia in order to diagnose early and correctly manage patients with the syndrome Assess the comorbidities associated with fibromyalgia that cause physical and emotional dysfunction and tailor treatment to individual patients' level and type of dysfunction Review current clinical recommendations for fibromyalgia and evaluate management strategies that have potential to decrease your patients' experience of pain Cite data that appraise intervention effectiveness in order to improve patient understanding and overcome barriers to integrating effective treatment options into therapy

PRACTICAL STRATEGIES FOR THE DIAGNOSIS AND MANAGEMENT OF OSTEOARTHRITIS IN WOMEN Supported by an educational grant to the FBHC from Merck & Co., Inc.
Faculty Maureen McMahon, MD Assistant Professor of Medicine/Rheumatology Division of Rheumatology David Geffen School of Medicine University of California, Los Angeles Los Angeles, CA Learning Objectives Review the presentation of osteoarthritis (OA) in order to make a correct diagnosis and provide patients with appropriate management Evaluate the pharmacologic and nonpharmacologic approaches to management of OA to improve patients' pain and functioning Assess the role of cyclooxygenase (COX)-2 inhibitors in the management of OA and identify safety considerations as they relate to individual patients' risk factors

REDUCING THE BURDEN OF CERVICAL CANCER AND HPV-RELATED GENITAL WARTS Supported by and educational grant to the FBHC from Merck & Co., Inc.
Faculty J. Thomas Cox, MD Director, Women's Clinic University of California, Santa Barbara Santa Barbara, CA Learning Objectives Describe the causal relationship of human papillomavirus (HPV) to genital warts and HPV to cervical cancer (CCA) and other lower genital tract cancers in order to better educate patients Review the current clinical guidelines for CCA screening and apply this knowledge to clinical practice to improve patient outcomes Understand the current screening strategies and their limitations due to socioeconomic, educational, cultural, and religious barriers to insure early and optimum diagnoses of CCA in patients Discuss the role of HPV prophylactic vaccines in reducing the incidence of genital warts and precancerous lesions, as well as CCA, and identify patients in your practice who may benefit from these vaccines

ROLE OF ACE INHIBITORS IN CVD RISK REDUCTION: BENEFITS BEYOND BLOOD PRESSURE CONTROL Supported by an educational grant to the FBHC from King Pharmaceuticals, Inc.
Faculty Prakash Deedwania, MD, FAHA, FCCP, FACP, FACC Chief, Cardiology Division VACCHCS/UCSF Fresno, CA Professor of Medicine School of Medicine University of California, San Francisco San Francisco, CA Learning Objectives Identify the clinical data supporting the aggressive management of hypertension (HTN) in women and demonstrate ways to prevent and treat HTN to reduce complications in female patients Review current approaches to HTN management in order to improve patient outcomes Compare the specific cardioprotective and renoprotective benefits of HTN therapies in order to make appropriate treatment decisions for individual patients Compare and contrast the advantages and disadvantages of ACEIs versus ARBs, and evaluate the role of combining the two agents in order to prescribe the best possible therapy for individual patient response

SEX: WHO'S DOING WHAT AND HOW TO TALK ABOUT IT WITH COMFORT
Faculty JoAnn Woodward, RNC, BSN, NP Maricopa Obstetrics and Gynecology Associates Phoenix, AZ Learning Objectives Recognize the importance of assessing sexual function in the healthcare of middle-aged and older adults Incorporate assessment of sexual function and risk for STIs into routine health care of adults Identify factors that may affect sexual function in men and women Provide appropriate treatment, counseling, or referral to patients experiencing sexual problems

SEXUAL FUNCTION IN WOMEN
Faculty Audrey E. Curtis, MD Lead Physician Division of Urogynecology and Pelvic Floor Medicine Northwest Kaiser Permanente Portland, OR Learning Objectives Recognize the prevalence of female sexual dysfunction (FSD) and routinely screen patients to identify those with FSD in order to improve quality of life Discuss data on female patients' desire to have clinicians initiate dialogue about FSD and implement procedures for improving physician/patient communication in order to better educate patients Review the etiologies of FSD and determine which pharmacologic and nonpharmacologic treatments are effective in improving patient outcomes Evaluate the clinical data on various pharmacologic options and identify the patients in your practice who would benefit from individualized treatment

SJÖGREN'S SYNDROME - CHALLENGES OF DIAGNOSIS AND MANAGEMENT Supported by an educational grant to the FBHC from Daiichi Sankyo, Inc.
Faculty Ava J. Wu, DDS Associate Clinical Professor Co-Director, Sjögren's Syndrome Clinic University of California, San Francisco San Francisco, CA Learning Objectives Review the various diagnostic tests available for Sjögren's syndrome (SS) and appropriately utilize them to make earlier and better diagnoses for improved patient mortality and morbidity Recognize the diverse presentation of symptoms and comorbidities associated with SS to address all manifestations of the disease, prevent potential complications, and improve patient response to care Evaluate the treatment options for SS and implement them in your practice for more successful and patient-specific treatment regimens Underscore the association of SS with underlying autoimmune connective tissue disorders such as rheumatoid arthritis, systemic lupus erythematosus, or scleroderma and highlight the positive impact that referral to a rheumatologist has on improving patient outcomes

STRESS URINARY INCONTINENCE (SUI): WHAT MATTERS? CONSENSUS RECOMMENDATIONS FROM AN EXPERT PANEL
Faculty Marian Sassetti, MD, FAAFP Family Physician Lake Street Family Physicians Oak Park, IL Assistant Professor Rush Medical College Chicago, IL Learning Objectives Recognize the prevalence and risk factors of stress urinary incontinence (SUI) and its impact on quality of life in order to identify patients who may require assessment Summarize the diagnosis of SUI and discuss patient barriers for seeking treatment in order to prescribe practical and individualized solutions for improving patient outcomes Identify behavioral and medical approaches to SUI management and formulate strategies to enhance treatment plans for SUI patients Cite recent clinical research and advances in SUI treatment to facilitate better patient options for improved satisfaction and quality of life

TOP SELLING DIETARY SUPPLEMENTS
Faculty Tieraona Low Dog, MD Director of Education Program in Integrative Medicine Clinical Assistant Professor Department of Medicine University of Arizona School of Medicine Tucson, AZ Learning Objectives Recognize the prevalence of dietary supplement use among women and review treatment recommendations that complement patients' use of supplements Identify which dietary supplements have strong evidence of benefit to support the informed decisions of patients with regard to their use Discuss the benefits of dietary supplements in the prevention of multiple diseases and highlight the need to incorporate relevant counseling for female patients

UNDERSTANDING SYSTEMIC LUPUS ERYTHEMATOSUS
Faculty Maureen McMahon, MD Assistant Professor of Medicine/Rheumatology Division of Rheumatology David Geffen School of Medicine University of California, Los Angeles Los Angeles, CA Learning Objectives Review updated criteria and available testing to properly diagnose SLE and identify patients who may benefit from early referral to a specialist, thus reducing patient morbidity and mortality Identify and differentiate the key risk factors of SLE in order to improve diagnosis rates for better patient outcomes Recognize the serious complications that can arise from SLE in order to reduce the negative physical and emotional symptoms of patients Evaluate the available pharmacologic and nonpharmacologic options for the treatment of various types of lupus in order to decrease symptoms and improve patient quality of life

UPDATES IN THE DIAGNOSIS AND MANAGEMENT OF CERVICAL DYSPLASIA, CERVICAL CANCER, AND OVARIAN CANCER
Faculty Andrew John Li, MD Faculty Physician Division of Gynecologic Oncology Cedars-Sinai Medical Center Assistant Professor-in-Residence Department of Obstetrics and Gynecology David Geffen School of Medicine University of California, Los Angeles Los Angeles, CA Learning Objectives Describe the early signs and symptoms of ovarian cancer and evaluate high-risk patients to determine the need for early treatment Cite the benefits of oral contraceptive therapy in preventing ovarian cancer and identify at-risk patients for whom this treatment would be appropriate Review current clinical guidelines on screening for cervical cancer and determine which patients should be screened based on age, risk factors, and sexual activity Recognize the disproportionate impact of cervical cancer on certain socioeconomic groups and target these higher-risk patients to prevent increased morbidity and mortality

UTERINE CANCER: NEW CONCEPTS IN EARLY DETECTION, SCREENING, AND MANAGEMENT
Faculty Andrew John Li, MD Faculty Physician Division of Gynecologic Oncology Cedars-Sinai Medical Center Assistant Professor-in-Residence Department of Obstetrics and Gynecology David Geffen School of Medicine University of California, Los Angeles Los Angeles, CA Learning Objectives Recognize the symptoms of uterine cancer to detect malignancy early and decrease patient morbidity and mortality Review prevention recommendations and treatment modalities for uterine cancer to improve patient outcomes Examine the association of tamoxifen treatment for breast cancer with the development of endometrial or uterine pathologies